Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
15.88
+0.50 (3.25%)
At close: May 22, 2026, 4:00 PM EDT
15.60
-0.28 (-1.76%)
After-hours: May 22, 2026, 7:35 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $84 million as of May 22, 2026. Its market cap has increased by 588.93% in one year.
Market Cap
84.00M
Enterprise Value
37.36M
1-Year Change
588.93%
Ranking
Category
Stock Price
$15.88
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $84.00M, a decrease of -79.29%. That is a compound annual growth rate of -27.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 84.00M | 189.82% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 81.49M |
| Atara Biotherapeutics | 80.44M |
| eXoZymes | 79.70M |
| MindWalk Holdings | 78.97M |
| MAIA Biotechnology | 78.43M |
| OS Therapies | 76.93M |
| Rein Therapeutics | 75.67M |
| Acrivon Therapeutics | 75.33M |